Anoop Enjeti

Anoop Enjeti is a Conjoint Associate Professor at the University of Newcastle and a dual-fellowship clinician-researcher in Haematology. He holds clinical appointments as Senior Staff Specialist at Calvary Mater Hospital and Director of Haematology for NSW Health Pathology. His research spans translational haematology, clinical trials in AML/MDS, proteogenomics, and thrombosis.

Education:

• MBBS
• MD (Pondicherry University)
• FRCP (UK)
• FRCPA
• FASCP
• FACP
• MClin Epid (Molecular & Genetic Epidemiology, University of Newcastle)
• Grad Cert Bioethics (Monash University)
• Master Cert Healthcare Leadership (Cornell University)
• Post Grad Cert Nanotechnology (Oxford University)
• Cert Competence Lymphoma (Ulm University)
• PhD (University of Newcastle)

Research Focus: Enjeti leads clinical trials in haematological malignancies, translational diagnostics, and molecular biology of leukemia. His work includes proteogenomic profiling, E-selectin antagonism to overcome chemoresistance, and studies on microvesicles/miRNA in clonal haematopoiesis. He co-leads the HMRI Precision Medicine Program.

Scientific Contributions:

• Established NSW-wide molecular haematology sequencing platform
• Published >65 peer-reviewed articles on AML/MDS
• Secured $7M+ in competitive research funding
• Key roles in Australasian Leukaemia & Lymphoma Group (ALLG)

Awards:

• 2016 Visiting Fellowship (Terry Fox Foundation, Canada)
• 2017-2020 Translational Research Fellowship (Pathology NSW)
• 2019 NHMRC Ideas Grant (co-lead with Nikki Verrills)